AnandRathi

Beta Drugs Ltd Fundamental Analysis

Last Updated Date: 23 Oct 2026
₹1,894.60
-76.40 (-3.88%)

Beta Drugs Ltd (Beta Drugs Ltd) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹2,100 crore.

Beta Drugs Ltd Overview

Market cap₹2,100 Crs
Volume1,55,586
Prev. Close₹1,971.00
Year range₹990.10 - ₹2,807.90
ISININE351Y01019

Beta Drugs Ltd Fundamentals

ROCE(TTM)9.27%
P/E Ratio (TTM)115.17
P/B Ratio6.61
Debt to Equity0.07
ROE5.74%
EPS (TTM)16.45
Dividend Yield0.00%
Book Value286.63
Profit Margin8.34%
Operating Margin10.30%

Beta Drugs Ltd Historical Performance

1 Month Return-13.40%
6 Month Return42.63%
3 Year Return120.50%
3 Month Return-16.80%
1 Year Return4.12%
5 Year Return251.19%

Beta Drugs Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research